1 |
Anand A, Zayac A, Curtiss C, et al. Pulmonary lymphoepithelioma-like carcinoma disguised as squamous cell carcinoma [J]. J Thorac Oncol, 2018, 13(5): e75-e76.
|
2 |
Liang Y, Wang L, Zhu Y, et al. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up [J]. Cancer, 2012, 118(19): 4748-4758.
|
3 |
Xie M, Wu X, Wang F, et al. Clinical significance of plasma Epstein-Barr virus DNA in pulmonary lymphoepithelioma-like carcinoma (LELC) patients [J]. J Thorac Oncol, 2018, 13(2): 218-227.
|
4 |
Chen B, Chen X, Zhou P, et al. Primary pulmonary lymphoepithelioma-like carcinoma: a rare type of lung cancer with a favorable outcome in comparison to squamous carcinoma [J]. Respir Res, 2019, 20(1): 262.
|
5 |
Chang YL, Yang CY, Lin MW, et al. PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy [J]. Lung Cancer, 2015, 88(3): 254-259.
|
6 |
Xie Z, Liu L, Lin X, et al. A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung [J]. Mod Pathol, 2020, 33(4): 626-638.
|
7 |
Ma H, Wu Y, Lin Y, et al. Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma in 41 patients [J]. Eur J Radiol, 2013, 82(8): 1343-1346.
|
8 |
Zhou N, Lin Y, Peng X, et al. Thorough survey and analysis of pulmonary lymphoepithelioma-like carcinoma in Macau and multimodality treatment for advanced disease [J]. Lung Cancer, 2019, 138: 116-123.
|
9 |
黄雁, 刘琴, 陈淮, 等. 肺淋巴上皮瘤样癌CT表现 [J] 中国医学影像技术, 2019, 35(5): 711-715.
|
10 |
蒋牧良, 龙莉玲, 秦雯, 等. 原发性肺淋巴上皮瘤样癌影像表现与病理分析 [J]. 中华放射学杂志, 2016, 50(2): 91-94.
|
11 |
Yeh YC, Kao HL, Lee KL, et al. Epstein-Barr virus-associated pulmonary carcinoma: proposing an alternative term and expanding the histologic spectrum of lymphoepithelioma-like carcinoma of the lung [J]. Am J Surg Pathol, 2019, 43(2): 211-219.
|
12 |
Wang L, Lin Y, Cai Q, et al. Detection of rearrangement of anaplastic lymphoma kinase (ALK) and mutation of epidermal growth factor receptor (EGFR) in primary pulmonary lymphoepithelioma-like carcinoma [J]. J Thorac Dis, 2015, 7(9): 1556-1562.
|
13 |
彭大云, 廖秋林, 陈晓东, 等. 肺原发淋巴上皮样癌18例临床病理研究 [J]. 中国临床研究, 2017, 30(4): 467-470.
|
14 |
Qin Y, Gao G, Xie X, et al. Clinical features and prognosis of pulmonary lymphoepithelioma-like carcinoma: summary of eighty-five cases [J]. Clin Lung Cancer, 2019, 20(3): e329-e337.
|
15 |
Lin Z, Fu S, Zhou Y, et al. First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma [J]. Lung Cancer, 2019, 137: 100-107.
|
16 |
Feng WH, Hong G, Delecluse HJ, et al. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas [J]. J Virol, 2004, 78(4): 1893-1902.
|
17 |
Yin K, Feng HB, Li LL, et al. Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma [J]. Thorac Cancer, 2020, 11(2): 346-352.
|
18 |
Jiang L, Wang L, Li PF, et al. Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma [J]. Onco Targets Ther, 2015, 8: 1451-1457.
|
19 |
He J, Shen J, Pan H, et al. Pulmonary lymphoepithelioma-like carcinoma: a surveillance, epidemiology, and end results database analysis [J]. J Thorac Dis, 2015, 7(12): 2330-2338.
|
20 |
彭红, 韩宝惠, 李小青, 等. 1279例肺癌患者临床特征及生存率分析 [J]. 中国癌症杂志, 2011, 21(5): 354-358.
|